Matthew J Fanton

Title: Matthew J Fanton: Innovator in Vaccine Development

Introduction

Matthew J Fanton is a notable inventor based in Lincoln, NE (US). He has made significant contributions to the field of vaccine development, particularly through his innovative approaches to plant cell culture technology. With a total of 2 patents, his work has the potential to impact the production of proteinaceous agents used in vaccines.

Latest Patents

Fanton's latest patents focus on the preparation of vaccine master cell lines using recombinant plant suspension cultures. The subject invention provides a plant cell culture for producing proteinaceous agents. This includes a plant cell line that is stably transformed to express a transgene encoding a proteinaceous agent. The growth medium supports the growth of the plant cell culture while preventing the growth of Mycoplasmataceae and contains no materials of animal origin. The plant cell line is designed to be continuously passaged, ensuring consistent transgene expression during passaging. Additionally, it can be cryopreserved, allowing for the recovery of consistent transgene expression upon thawing.

Career Highlights

Matthew J Fanton is currently employed at Dow Agrosciences LLC, where he continues to advance his research in plant biotechnology. His work is crucial in developing safer and more effective vaccine production methods.

Collaborations

Fanton has collaborated with notable colleagues such as Charles A Mihaliak and Janis K McMillen. These partnerships have further enhanced the innovative research being conducted in his field.

Conclusion

Matthew J Fanton is a pioneering inventor whose work in vaccine development through plant cell culture technology holds great promise for the future of immunization. His contributions are paving the way for advancements in the production of vaccines that are both effective and safe.